Clinical Trial Update: Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial updates safety, tolerability, and pharmacokinetics of a single IV dose of ETI-204 in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inhalational Anthrax

Drugs mentioned

• ETI-204

Snippet

Sponsor: Elusys Therapeutics | Conditions: Inhalational Anthrax | Phase 1 | Status: COMPLETED | Results posted: 2019-04-08